BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2024 2:44:49 PM | Browse: 508 | Download: 1574
Publication Name World Journal of Virology
Manuscript ID 88660
Country Iran
Received
2023-10-04 06:35
Peer-Review Started
2023-10-04 06:37
First Decision by Editorial Office Director
2023-10-09 08:18
Return for Revision
2023-10-09 08:18
Revised
2023-11-09 19:41
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-12-22 00:10
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-12-29 07:00
Articles in Press
2023-12-29 07:00
Edit the Manuscript by Language Editor
2023-12-21 06:32
Typeset the Manuscript
2024-02-19 01:18
Publish the Manuscript Online
2024-03-11 14:44
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Meta-Analysis
Article Title Efficacy and safety of bamlanivimab in patients with COVID-19: A systematic review and meta-analysis
Manuscript Source Invited Manuscript
All Author List Behnam Amani, Lida Khodavirdilou, Kourosh Rajabkhah, Vida Kardan Moghaddam, Arash Akbarzadeh and Bahman Amani
ORCID
Author(s) ORCID Number
Bahman Amani http://orcid.org/0000-0002-2340-189X
Funding Agency and Grant Number
Corresponding Author Bahman Amani, MSc, Researcher, Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Qods Street, Keshavarz Blvd, Tehran 1416634793, Iran. b89amani@yahoo.com
Key Words SARS-CoV-2; COVID-19; Bamlanivimab; Monoclonal antibody; Meta-analysis
Core Tip The present study is the most comprehensive systematic review and meta-analysis on the efficacy and safety of bamlanivimab in the treatment of coronavirus disease 2019 (COVID-19). A significant difference was observed between the bamlanivimab and standard of care/placebo groups in terms of mortality rate, hospitalization rate, and emergency department visits. While the two groups exhibited no significant difference in terms of intensive care unit admission. The present results suggested that bamlanivimab might be effective and safe for the treatment of COVID-19.
Publish Date 2024-03-11 14:44
Citation Amani B, Khodavirdilou L, Rajabkhah K, Kardan Moghaddam V, Akbarzadeh A, Amani B. Efficacy and safety of bamlanivimab in patients with COVID-19: A systematic review and meta-analysis. World J Virol 2024; 13(1): 88660
URL https://www.wjgnet.com/2220-3249/full/v13/i1/88660.htm
DOI https://dx.doi.org/10.5501/wjv.v13.i1.88660
Full Article (PDF) WJV-13-88660-with-cover.pdf
Full Article (Word) WJV-13-88660.docx